In humans, IL-18 is produced by gut epithelial cells and macrophages and this production is increased during inflammatory bowel diseases[34], [35], [36], [37] validating the use of anti-IL-18 monoclonal antibody for Crohn’s disease (ongoing clinical trial NCT03681067). Here, IL18 is linked to Crohn disease.